Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts.
A growing body of evidence suggests the involvement of connective tissue growth factor (CTGF) in the development and maintenance of fibrosis and excessive scarring. As the expression of this protein requires an intact actin cytoskeleton, disruption of the cytoskeleton represents an attractive strategy to decrease CTGF expression and, consequently, excessive scarring. The small heat-shock-related protein (HSP20), when phosphorylated by cyclic nucleotide signaling cascades, displaces phospho-cofilin from the 14-3-3 scaffolding protein leading to activation of cofilin as an actin-depolymerizing protein. In the present study, we evaluated the effect of AZX100, a phosphopeptide analogue of HSP20, on transforming growth factor-beta-1 (TGF-beta1)-induced CTGF and collagen expression in human keloid fibroblasts. We also examined the effect of AZX100 on scar formation in vivo in dermal wounds in a Siberian hamster model. AZX100 decreased the expression of CTGF and type I collagen induced by TGF-beta1, endothelin, and lysophosphatidic acid. Treatment with AZX100 decreased stress fiber formation and altered the morphology of human dermal keloid fibroblasts. In vivo, AZX100 significantly improved collagen organization in a Siberian hamster scarring model. Taken together, these results suggest the potential use of AZX100 as a strategy to prevent excessive scarring and fibrotic disorders.
Lopes
Luciana B
LB
Center for Metabolic Biology, College of Liberal Arts and Sciences, Arizona State University, Tempe, Arizona, USA.
Furnish
Elizabeth J
EJ
Komalavilas
Padmini
P
Flynn
Charles R
CR
Ashby
Patricia
P
Hansen
Adam
A
Ly
Daphne P
DP
Yang
George P
GP
Longaker
Michael T
MT
Panitch
Alyssa
A
Brophy
Colleen M
CM
D048948:14-3-3 Proteins / Q000378:metabolism; D000818:Animals; D024042:Collagen Type I / Q000378:metabolism; D055513:Connective Tissue Growth Factor / Q000096:biosynthesis* / Q000378:metabolism; D006224:Cricetinae; D016232:Endothelins / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism*; D005355:Fibrosis / Q000188:drug therapy / Q000378:metabolism; D050886:HSP20 Heat-Shock Proteins / Q000378:metabolism*; D050888:Heat-Shock Proteins, Small / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007627:Keloid / Q000378:metabolism*; D008246:Lysophospholipids / Q000378:metabolism; D017111:Phodopus; D010750:Phosphoproteins / Q000737:chemistry / Q000494:pharmacology*; D010766:Phosphorylation; D053773:Transforming Growth Factor beta1 / Q000378:metabolism*
D048948:14-3-3 Proteins; C539010:AZX 100; D024042:Collagen Type I; D016232:Endothelins; D050886:HSP20 Heat-Shock Proteins; D050888:Heat-Shock Proteins, Small; D008246:Lysophospholipids; D010750:Phosphoproteins; D053773:Transforming Growth Factor beta1; D055513:Connective Tissue Growth Factor; C032881:lysophosphatidic acid
Mol Biol Cell. 2004 Jun;15(6):2707-19
15047866
J Biol Chem. 2000 Dec 1;275(48):37429-35
10976101
Plast Reconstr Surg. 2006 Jan;117(1):247-52
16404275
Eur J Dermatol. 1998 Dec;8(8):591-5
9889433
Science. 1999 Sep 3;285(5433):1569-72
10477521
Physiol Behav. 1997 Apr;61(4):477-84
9108564
FASEB J. 1998 Sep;12(12):1151-61
9737718
Cancer Res. 2001 Jan 15;61(2):474-7
11212234
Plast Reconstr Surg. 2005 Aug;116(2):675
16079716
J Surg Res. 2006 Sep;135(1):156-63
16564547
J Am Soc Nephrol. 2001 Sep;12(9):1853-1861
11518778
J Biol Chem. 2003 Nov 7;278(45):44305-11
12951326
Plast Reconstr Surg. 1998 Nov;102(6):1954-61
9810991
Surgery. 2004 Sep;136(3):573-8
15349104
Wound Repair Regen. 2004 Mar-Apr;12(2):169-74
15086768
J Am Coll Surg. 2007 Jul;205(1):78-88
17617336
Curr Gene Ther. 2004 Mar;4(1):123-36
15032619
Kidney Int. 1998 Apr;53(4):853-61
9551391
Pharm Res. 2004 Mar;21(3):389-93
15070086
J Cell Sci. 2006 Dec 1;119(Pt 23):4803-10
17130294
J Biol Chem. 2000 May 19;275(20):15220-5
10809757
Ann Plast Surg. 1999 Aug;43(2):179-84
10454326
FASEB J. 2003 Jul;17(10):1358-60
12738803
J Lab Clin Med. 1993 Oct;122(4):395-403
8228553
FASEB J. 2005 Feb;19(2):261-3
15598710
Curr Biol. 2002 Oct 1;12(19):1704-10
12361576
J Pathol. 2005 Oct;207(2):232-42
16052471
Psychoneuroendocrinology. 2004 Sep;29(8):1004-11
15219651
Dev Biol. 2002 Oct 15;250(2):393-405
12376112
Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H1871-81
12842814
Wound Repair Regen. 2003 Nov-Dec;11(6):411-8
14617279
J Surg Res. 2004 May 1;118(1):21-5
15093712
Am J Physiol Cell Physiol. 2007 May;292(5):C1732-8
17215322
Wound Repair Regen. 2005 Jan-Feb;13(1):7-12
15659031
Hepatology. 1999 Oct;30(4):968-76
10498649
J Biol Chem. 1999 Apr 16;274(16):11344-51
10196226
FASEB J. 2004 May;18(7):816-27
15117886
Nat Rev Mol Cell Biol. 2002 May;3(5):349-63
11988769
J Dermatol Sci. 2002 May;29(1):26-34
12007718
Am J Physiol Lung Cell Mol Physiol. 2008 Jan;294(1):L69-78
17993590
J Cell Physiol. 1999 Oct;181(1):153-9
10457363
Plast Reconstr Surg. 2003 May;111(6):1853-9
12711944
FASEB J. 1999 Oct;13(13):1774-86
10506580
J Vasc Surg. 2003 Apr;37(4):874-81
12663991
Int J Cancer. 2003 Dec 10;107(5):715-20
14566820
Plast Reconstr Surg. 2006 Jan;117(1):286-300
16404281
J Cell Physiol. 2006 Aug;208(2):336-43
16705627
Plast Reconstr Surg. 2006 Apr 15;117(5):1645-6
16641743
J Am Coll Surg. 2005 Sep;201(3):391-7
16125072
J Invest Dermatol. 1996 Apr;106(4):729-33
8618012
J Cell Sci. 1995 Mar;108 ( Pt 3):985-1002
7542672